Results 141 to 150 of about 32,135 (260)

Investigation of the sero-epidemiology of vaccine preventable diseases and common viral infections in French populations. [PDF]

open access: yesCommun Med (Lond)
Bloch E   +10 more
europepmc   +1 more source

Autoantibodies to Joint‐Related Peptides Are Associated With Onset of Rheumatoid Arthritis in Presymptomatic Seronegative Individuals

open access: yesArthritis &Rheumatology, EarlyView.
Objective To identify autoantibodies in presymptomatic individuals that associate with the onset of rheumatoid arthritis (RA) and to distinguish early RA from osteoarthritis (OA), particularly in individuals lacking classic RA serologic markers. Methods We analyzed serum and plasma from three cohorts: presymptomatic individuals who later developed RA ...
Outi Sareila   +12 more
wiley   +1 more source

Changing demographics and immunity to vaccine preventable diseases in people with HIV in Ireland. [PDF]

open access: yesBMC Infect Dis, 2022
Kerr C   +5 more
europepmc   +1 more source

Differences in SARS‐CoV‐2 Antigen Persistence in Individuals With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A RECOVER‐Adult Cohort Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective Individuals with systemic autoimmune rheumatic diseases (SARDs) are at risk for worse acute and post–acute COVID‐19 outcomes, though whether individuals with SARDs have longer persistence of viral antigens after COVID‐19 has not been studied.
Naomi J. Patel   +18 more
wiley   +1 more source

Brace yourselves, vaccine-preventable diseases are coming! The impact of war on polio and other vaccine-preventable diseases. [PDF]

open access: yesEXCLI J
Costa TG   +6 more
europepmc   +1 more source

African Vaccination Week as a catalyst for integrated services and immunisation equity: synthesis of implementation insights from countries in the WHO African Region

open access: yesBMJ Public Health
Charles Shey Wiysonge   +6 more
doaj   +1 more source

Vaccine preventable diseases in Germany

open access: yesWeekly releases (1997–2007), 1999
W Kiehl, Gernot Rasch, O Schaefer
openaire   +1 more source

Pharmacokinetics, effectiveness and safety of certolizumab pegol in children and adolescents with active juvenile idiopathic arthritis: 9+‐year results from a multicenter, open‐label study

open access: yesArthritis &Rheumatology, Accepted Article.
Objective To assess the pharmacokinetics, effectiveness, safety, and immunogenicity of certolizumab pegol (CZP) in polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods Pediatric Arthritis Study of Certolizumab Pegol (NCT01550003), a multicenter, open‐label study, enrolled patients 2–17 years with active pcJIA and inadequate response ...
Hermine I Brunner   +28 more
wiley   +1 more source

Home - About - Disclaimer - Privacy